| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Stoke Therapeutics, Inc. (STOK) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. STOK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.91M | $123.83M | - | |
| CEO | 380.0K | $12.05M | - | |
| Dir | 283.3K | $8.98M | - | |
| Other | 118.7K | $3.76M | - | |
| Dir | 110.9K | $3.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Kaye Edward M. Md47 | CEO | Sell | 42,350 | $15.43 | $653,529.16 | -42.8% | -7.8% | -37.6% | |
| May 1, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 10,000 | $11.37 | $113,653.00 | -80.1% | +26.1% | -14.6% | |
| Apr 17, 2024 | Skorpios Trust | 10% Owner | Sell | 3,600,000 | $11.60 | $41,760,000.00 | -24.9% | +25.8% | -34.4% | |
| Apr 1, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 9,426 | $13.23 | $124,684.30 | -79.1% | +2.8% | -53.8% | |
| Apr 1, 2024 | Nash Huw M.81 | COO &Cbo | Sale+OE | 61,329 | $13.23 | $811,211.75 | -99.4% | +2.8% | -53.8% | |
| Mar 28, 2024 | Allan Jonathan46 | General Counsel &Corp Sec | Sell | 5,126 | $13.20 | $67,667.91 | -49.2% | -4.3% | -46.6% | |
| Mar 19, 2024 | Tulipano Stephen J | CFO | Sale+OE | 4,116 | $6.10 | $25,101.84 | -16.6% | +169.0% | +42.4% | |
| Mar 19, 2024 | Allan Jonathan46 | General Counsel &Corp Sec | Sale+OE | 2,349 | $6.10 | $14,325.61 | -23.3% | +169.0% | +42.4% | |
| Mar 19, 2024 | Nash Huw M.81 | COO &Cbo | Sale+OE | 4,116 | $6.10 | $25,101.84 | -26.6% | +169.0% | +42.4% | |
| Mar 19, 2024 | Ticho Barry52 | Chief Medical Officer | Sale+OE | 4,116 | $6.10 | $25,101.84 | -26.4% | +169.0% | +42.4% |